It is recognized that around 5-10% of patients with asthma have severe disease which remains inadequately controlled; despite high-dose ICS/LABA and additional controller medication if required. Due to the associated morbidity, these patients represent an important segment of asthma population. This slide set focuses on the identification, management and advances in severe asthma.